Dear Editor,
The discovery of base-editing tools sheds new light on both basic biomedical research and clinical therapeutics.1,2 Although showing profound performance in a wide range of applications, current base editors have their limitations. In particular, the narrow editing windows of these base editors have significantly limited their targetable sites. In current base editors, the most frequent way to tether deaminase is to fuse it to the N-terminus of the Cas9 protein through flexible peptide linkers. Base editors derived from Streptococcus pyogenes Cas9 (SpyCas9) or its variants can efficiently edit desired bases in an ~5 nt wide window within the detached,non-target strand (NTS). Maximum editing typically occurs around positions 5–7, counting from the 5′ end of the protospacer, which is about 15 nt away from the protospacer adjacent motif (PAM).1,3 Bases outside this narrow window are poorly edited. Given that there are very limited choices for PAMs, many targets were not able to be targeted by current base editors due to the lack of well-positioned PAMs.
To overcome this obstacle, we designed a novel editing system based on the position information of the Cas9/DNA/sgRNA complex. Recently, a cryo-electron microscopy structure of the Cas9/DNA/sgRNA complex was resolved, which for the first time presented the scenario with detached with the NTS included.4 According to this structure, parts of PI domain and RuvC3 domain lie just adjacent to and on the same side as the NTS. The C-terminus of the Cas9 protein lies to the other side, opposite to the NTS, and the N-terminus lies between the PI domain and the C-terminus. Consistent with the position information revealed by this structure, fusion of cytosine deaminases, such as APOBEC1, to the N-terminus but not to the C-terminus, with finite linkers, possesses the ability to deaminate cytosine within the NTS. Similarly, lengthening the linker that connected the deaminase and Cas9 protein increased both the editing efficiency and the width of editing window, suggesting that a relatively short distance between deaminases and the NTS yielded a high editing efficiency and wide editing window.5,6 Therefore, we hypothesized that inlaying deaminases directly into the PI or RuvC3 domain without interrupting their activities would increase the editing efficiency and broaden the editing window.
To test our hypothesis, we analyzed the secondary structure of this region for proper inlay sites. We found two candidate sites that were located in unstructured loops within the RuvC and PI domains (Fig. 1a), that is, site 1054 (between G1054 and E1055) and site 1246 (between G1246 and S1247), which we named BE-RuvCGE and BE-PIGS, respectively. We inserted APOBEC1 into these two sites using a pair of flexible linkers (Fig. 1b). Transfection of these novel editors together with a previously reported sgRNA into mammalian cells revealed that BE-PIGS induced robust C-to-T base editing while BE-RuvCGE caused mild editing (Fig. 1c, d). This observation was further confirmed with additional two sgRNAs (Fig. S1). On average, BE-PIGS exhibited nearly two-fold greater editing activity than BE- RuvCGE (23.67% vs 12.67%). Therefore, we focused on the BE- PIGS base editor for further characterization.
We compared the editing efficiency of BE-PIGS to that of BE3 and BE4, two of the most popular and efficient base editors.7 BE-PIGS showed a slightly low editing efficiency than BE3 and BE4 in the cytosines (Cs) located within the editing window of BE3 or BE4 (positions 4–8, numbering the PAM as positions 21–23), while performing much higher editing in Cs downstream of this window (Fig. 1e), indicating that the BE-PIGS base editor might have a wider editing window than that of BE3 or BE4. To further confirm this, we characterized the editing window of BE-PIGS with additional targets that possess multiple Cs. As shown in Fig. 1f, BE-PIGS achieved considerable editing in Cs that were only six bases away from the PAM (position 14). Together, these data demonstrated that inlaying APOBEC1 into the PI domain significantly increased the editing width (Fig. 1g), ranging from position 4 to position 14, with the maximum editing occurring around position 7–13 (Fig. 1g). This finding was in consistent with a recent publication in which tethering deaminase to the PI domain of a circular permuted Cas9 also expanded the editing window.8
Then, we examined the effects of the length of linker, connecting the deaminase and the Cas9 PI domain on the editing efficiency and window. We first shortened the N-terminal linker, keeping the C-terminal linker unchanged. We showed that shortening the N-terminal linker from 16 aa to 8 aa or 3 aa generally reduced the editing efficiency in all targetable Cs, but did not obviously change the width of the editing window. Similar effects were also observed when the C-terminal linker was shortened from 32 aa to 20 aa or 5 aa (Fig. S3).
Recently, a BE system based on Sun-tag (GCN4/scFv) mediated linkage of deaminase and Cas9 was shown to expand the editing window (BE-PLUS).9 To test whether the Sun-tag system is also feasible for and further expands the editing window of BE-PIGS, we inserted six copies of GCN4 helices into the PIGS site to form PIGS-GCN4. We showed that transfections of this construct together with scFv tagged APOBEC1 yielded a slight reduction in editing in a set of target sites, and did not further enlarge the editing window (Fig. S4).
Previous studies have revealed that truncating the spacers within SpyCas9 sgRNAs reduced off-target effects and altered the editing window in SpyCas9 derived base editors,6,10 we therefore tested the effects of sgRNA truncation on our base-editing system. We truncated the spacers within a set of sgRNAs from 20 to 17 or 18 nt. In one out of the three target sites tested, the truncated guide RNA led to a narrowed editing window (Fig. S5). However, this phenomenon was not observed in the rest target sites (Fig. S5), suggesting that the effects of sgRNA truncation on the editing window are protospacer specific. In summary, we generated a novel base-editing system by inlaying deaminase into the PI domain of the SpyCas9 protein, BE-PIGS. We showed that internally inlayed deaminase or GCN4 tag retained their ability to induce base substitution but did not destroy Cas9 activity for target recognition. BE-PIGS has a much wider editing window than BE3 or BE4, which is particularly useful in cases where wide editing ranges are required or targeted bases are extremely close to the PAM.
References
Komor, A. C. et al. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016).
Gaudelli, N. M. et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 551, 464–471 (2017).
Komor, A. C., Badran, A. H. & Liu, D. R. Editing the Genome Without Double-Stranded DNA Breaks. ACS Chem. Biol. 13, 383–388 (2018).
Anders, C., Niewoehner, O., Duerst, A. & Jinek, M. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513, 569–573 (2014).
Kim, Y. B. et al. Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat. Biotechnol. 35, 371–376 (2017).
Tan, J., Zhang, F., Karcher, D. & Bock, R. Engineering of high-precision base editors for site-specific single nucleotide replacement. Nat. Commun. 10, 439 (2019).
Komor, A. C. et al. Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity. Sci. Adv. 3, eaao4774 (2017).
Huang, T. P. et al. Author Correction: Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors. Nat. Biotechnol. 37, 820 (2019).
Jiang, W. et al. BE-PLUS: a new base editing tool with broadened editing window and enhanced fidelity. Cell Res. 28, 855–861 (2018).
Fu, Y. et al. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 32, 279–284 (2014).
Acknowledgements
We thank Dr. Xingxu Huang from ShanghaiTech University for kindly providing BE-plus plasmids. This work was supported by the Hi-Tech Research & Development (863) Program of China (2015AA020309), National Natural Science Foundation of China (81771220) and Salubris Academician Workstation for Innovative Biopharmaceuticals (no. 2017B090904017).
Author information
Authors and Affiliations
Contributions
Y. W., L. Z., and N. L. performed the experiments. Y. W. and S.Y. designed the experiments and wrote the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, Y., Zhou, L., Liu, N. et al. BE-PIGS: a base-editing tool with deaminases inlaid into Cas9 PI domain significantly expanded the editing scope. Sig Transduct Target Ther 4, 36 (2019). https://doi.org/10.1038/s41392-019-0072-7
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41392-019-0072-7
This article is cited by
-
Harnessing the evolving CRISPR/Cas9 for precision oncology
Journal of Translational Medicine (2024)
-
CRISPR technologies for genome, epigenome and transcriptome editing
Nature Reviews Molecular Cell Biology (2024)
-
Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope
Nature Communications (2024)
-
Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
Molecular Biomedicine (2023)
-
Engineered CRISPR prime editors with compact, untethered reverse transcriptases
Nature Biotechnology (2023)